Neuroone Medical Technologies (NMTC) Non-Current Assets (2011 - 2026)

Neuroone Medical Technologies (NMTC) has reported Non-Current Assets for 12 consecutive years, with $397294.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets fell 38.76% year-over-year to $397294.0; the trailing twelve-month figure through Jun 2026 stood at $1.9 million (down 32.88% YoY), and the FY2025 full-year result was $559363.0, down 24.31% from the prior year.
• Non-Current Assets fell to $397294.0 in Q2 2026 per NMTC's latest filing, from $461160.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $879353.0 in Q2 2023 and bottomed at $397294.0 in Q2 2026.
• Historically, Non-Current Assets has averaged $676840.5 across 5 years, with a median of $689195.5 in 2022.
• The sharpest annual moves came in 2023 and 2026: Non-Current Assets soared 37.04% in 2023, then sank 38.76% in 2026.
• Over 5 years, Non-Current Assets stood at $693233.0 in 2022, then advanced by 5.21% to $729371.0 in 2023, then increased by 7.31% to $782665.0 in 2024, then slumped by 34.77% to $510525.0 in 2025, then decreased by 22.18% to $397294.0 in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $397294.0, $461160.0, and $510525.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.